# early-onset AD, and in April 2023 and July 2023, we reported positive interim results FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/early-onset-ad-and-in-april-2023-and-july-2023-we-reported-positive-interim-resu

> No upcoming FDA catalysts in early-onset AD, and in April 2023 and July 2023, we reported positive interim results; 2 past events are recorded.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Apr 2023 | [Mivelsiran trial start](https://sec-api.dev/pdufa/mivelsiran) | ALNY | early-onset AD, and in April 2023 and July 2023, we reported positive interim results | completed | "In early 2022, we initiated a Phase 1 clinical trial of mivelsiran in patients with early-onset AD, and in April 2023 and July 2023, we reported positive interim results." ([SEC Form 10-K](https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm)) |
| Apr 2023 | [Mivelsiran interim data readout](https://sec-api.dev/pdufa/mivelsiran) | ALNY | early-onset AD, and in April 2023 and July 2023, we reported positive interim results | completed, positive | "In early 2022, we initiated a Phase 1 clinical trial of mivelsiran in patients with early-onset AD, and in April 2023 and July 2023, we reported positive interim results." ([SEC Form 10-K](https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm)) |

## Drugs

- [Mivelsiran](https://sec-api.dev/pdufa/mivelsiran) (ALNY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/early-onset-ad-and-in-april-2023-and-july-2023-we-reported-positive-interim-resu.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "early-onset AD, and in April 2023 and July 2023, we reported positive interim results FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/early-onset-ad-and-in-april-2023-and-july-2023-we-reported-positive-interim-resu

```bibtex
@misc{secapidev_indications_early_onset_ad_and_in_april_2023_and_july_2023_we_reported_positive_interim_resu_20261116,
  title        = {early-onset AD, and in April 2023 and July 2023, we reported positive interim results FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/early-onset-ad-and-in-april-2023-and-july-2023-we-reported-positive-interim-resu}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_early_onset_ad_and_in_april_2023_and_july_2023_we_reported_positive_interim_resu_20261116","title":"early-onset AD, and in April 2023 and July 2023, we reported positive interim results FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/early-onset-ad-and-in-april-2023-and-july-2023-we-reported-positive-interim-resu","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
